Across TCGA pan-cancer cohorts, MIR4255 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR4255 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR4255 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4255 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.
UCEC, BLCA, and LGG are the cancer types where MIR4255 RNA most reproducibly stratifies survival.